Skip to main content

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

Completed · Phase 2 · NCT06384157

Conditions: Opioid Use Disorder

At a glance

Research payments reported, 2025
$10.4M
U.S. investigators named
36
Sites paid
61
Planned or actual enrollment
300

About the trial

Sponsor
Indivior Inc.
Tested
INDV-2000 (drug), Placebo (other)
Dates
Started 2024-06-10; completion 2025-11-03
Results posted
Not yet

The purpose of this study is to measure safety and efficacy and to determine dose-response relationship for INDV-2000 in participants with moderate to severe Opioid Use Disorder (OUD) who are new to treatment, have recently initiated or completed short-term medically supervised withdrawal with transmucosal (TM) buprenorphine, and are interested in transitioning to a non opioid treatment.

From ClinicalTrials.gov, last updated 2025-12-16. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Indivior Inc. reported $10.4M in research payments for this study in 2025 (845 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Imagine Research of Florida DBA Imagine Research of PAlm Beach County $2.3M
  • Clinical Research of Broward County DBA Clinical Research Center of Florida LLC $2.1M
  • Pahl Pharmaceutical Professionals LLC $579,315
  • Boeson Research LLC $461,394
  • Artemis Headlands LLC $438,365
  • Quantum Clinical Trials LLC $434,590
  • Prisma Health Greer Memorial Hospital, SC $368,920
  • Unity Clinical Research LLC $331,035
  • Progressive Clinical Research LLC $323,330
  • Alpine Research Organization Inc $295,004
  • Vitalix Clinical Inc $290,685
  • Boyett Health Services $282,770
  • Insite Clinical Research LLC $273,877
  • Monroe Biomedical Research LLC $208,756
  • Annex Clinical Corporation $197,213
  • Maryland Treatment Center $192,005
  • Erg - Midwest Clinical Research Center LLC $137,235
  • Oasis Clinical Trials $120,002
  • Sandhill Research $114,365
  • Imagine Res of PAlm Beach Cty $89,391
  • Formoso PAin Specialists PA DBA Bold City Clinical Research $87,076
  • West Clinical Research $76,627
  • Sp Research PLLC DBA Rivus Wellness and Research Institute $72,404
  • Vitalix Kissimmee LLC $66,637
  • Clinical Research Center of Florida $66,116
  • Innovative Clinical Research Inc $63,667
  • Elite Clinical Studies LLC $62,739
  • Hd Research LLC Co Erg Holding Company LLC $37,203
  • Insight Research Institute $34,280
  • El PAso Clinical Trials $34,229
  • Precise Clinical Research Inc $33,198
  • Ima Evaluations LLC DBA Ima Clinical Research $24,575
  • Arch Clinical Trials LLC $21,200
  • Agile Clinical Research Trials LLC $20,800
  • Boeson Research Pvu $20,288
  • Pahl Pharmaceutical Professionals $19,069
  • Imagine Research of PAlm Beach County $16,944
  • Boyett Health Services Inc $16,239
  • Quantum Clinical Trials $15,453
  • Prisma Health Addiction $14,166
  • Empire Clinical Research $13,600
  • Dr Vando Medical Services $12,704
  • Annex Clinical Corporation on Behalf of Dr Vando Medical Services $12,163
  • Vitalix Clinical $12,016
  • Bold City Clin Res $10,019
  • Insite Clinical Research $9,987
  • Progressive Clinical Res LLC $8,481
  • Artemis Inst for Clin Res $8,124
  • North County Clinical Research Inc $7,178
  • Unity Clinical Research $6,627
  • Alpine Research Organization $6,485
  • Vitalix Kissimmee $5,717
  • Oasis Clinical Research $5,469
  • Midwest Clinical Research Center $4,215
  • Precise Clinical Research $3,713
  • Rivus Wellness & Research Institute $2,829
  • Richmond Behavioral Assoc $2,708
  • Elite Clinical Trials $2,708
  • Arch Clinical Trials $2,708
  • Monroe Biomedical Research $2,119
  • Accel Res Sites $514

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.